123 related articles for article (PubMed ID: 2235201)
1. An industrial hygiene approach to controlling nonpatient exposure to ribavirin aerosol.
Kayman L
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S100-1. PubMed ID: 2235201
[No Abstract] [Full Text] [Related]
2. Environmental exposure to ribavirin aerosol.
Bradley J
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S95-8. PubMed ID: 2235216
[No Abstract] [Full Text] [Related]
3. Reproductive risk assessment with occupational exposure to ribavirin aerosol.
Harrison R
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S102-5. PubMed ID: 2235202
[No Abstract] [Full Text] [Related]
4. Use of an in-house-built ribavirin aerosol evacuation system to control incidental employee exposure to ribavirin aerosol.
Mueller BA; Waldon VK
J Clin Eng; 1996; 21(1):46-50. PubMed ID: 10154627
[TBL] [Abstract][Full Text] [Related]
5. Protecting hospital employees and visitors from aerosolized ribavirin.
Munzenberger PJ; Walker PC
Am J Hosp Pharm; 1994 Mar; 51(6):823-6. PubMed ID: 8010325
[No Abstract] [Full Text] [Related]
6. Ribavirin aerosol: methods for reducing employee exposure.
Arnold SD; Alonso R
AAOHN J; 1993 Aug; 41(8):382-92. PubMed ID: 8397555
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a double-enclosure double-vacuum unit scavenging system for ribavirin administration.
Kacmarek RM; Kratohvil J
Respir Care; 1992 Jan; 37(1):37-45. PubMed ID: 10145580
[TBL] [Abstract][Full Text] [Related]
8. Update: ribavirin exposure.
Healthc Hazard Mater Manage; 1991 Jan; 4(4):1-4. PubMed ID: 10111085
[No Abstract] [Full Text] [Related]
9. Care-giver protection from exposure to aerosolized pharmacologic agents. Is it necessary?
Kacmarek RM
Chest; 1991 Oct; 100(4):1104-5. PubMed ID: 1914567
[No Abstract] [Full Text] [Related]
10. Ribavirin: is there a risk to hospital personnel? Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1991 Feb; 144(3):285-6. PubMed ID: 1989706
[No Abstract] [Full Text] [Related]
11. Canada and the U.S. differ on ribavirin risk.
Healthc Hazard Mater Manage; 1991 Jun; 4(9):8. PubMed ID: 10112449
[No Abstract] [Full Text] [Related]
12. Assessing exposures of health-care personnel to aerosols of ribavirin--California.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Sep; 37(36):560-3. PubMed ID: 3137440
[No Abstract] [Full Text] [Related]
13. Leads from the MMWR. Assessing exposures of health-care personnel to aerosols of ribavirin--California.
JAMA; 1988 Oct; 260(13):1844-5. PubMed ID: 3418843
[No Abstract] [Full Text] [Related]
14. Aerosol consensus statement. Consensus Conference on Aerosol Delivery.
Chest; 1991 Oct; 100(4):1106-9. PubMed ID: 1914568
[No Abstract] [Full Text] [Related]
15. Reduced environmental exposure to aerosolized ribavirin using a simple containment system.
Torres A; Krilov LR; Jacobson JM; Kelly KJ; Havens PL
Pediatr Infect Dis J; 1991 Mar; 10(3):217-21. PubMed ID: 2041670
[TBL] [Abstract][Full Text] [Related]
16. The exposure of health care workers to ribavirin aerosol.
Guglielmo BJ; Jacobs RA; Locksley RM
JAMA; 1989 Apr; 261(13):1880-1. PubMed ID: 2926922
[No Abstract] [Full Text] [Related]
17. Aerosol consensus statement--1991. American Association for Respiratory Care.
Respir Care; 1991 Sep; 36(9):916-21. PubMed ID: 10145538
[No Abstract] [Full Text] [Related]
18. Occupational exposure to ribavirin aerosols.
Lancet; 1988 Oct; 2(8617):976. PubMed ID: 2902429
[No Abstract] [Full Text] [Related]
19. Occupational exposures to aerosolized pharmaceuticals and control strategies.
Decker JA; Seitz TA; Shults RA; Deitchman S; Tucker SP; Belinky BR; Clark NJ
Scand J Work Environ Health; 1992; 18 Suppl 2():100-2. PubMed ID: 1514061
[No Abstract] [Full Text] [Related]
20. Prioritizing research questions on the safety of ribavirin in the treatment of respiratory syncytial virus infections.
Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S122-3. PubMed ID: 2235207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
